BOSSRA
LRMR icon

B.O.S.S. Retirement Advisors’s Larimar Therapeutics LRMR Stock Holding History

B.O.S.S. Retirement Advisors’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,154
Closed -$54.7K – 169
2026
Q1 		$54.7K Sell
12,154
-2,285
-16% -$9.13K 0.02% 173
2025
Q4 		$55K Buy
14,439
+1,720
+14% +$6.69K 0.02% 170
2025
Q3 		$41.1K Buy
+12,719
New +$47.7K 0.01% 193

Other funds holding LRMR

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

B.O.S.S. Retirement Advisors's LRMR Position: Q2 2026 in Review

B.O.S.S. Retirement Advisors sold out of Larimar Therapeutics (LRMR) in Q2 2026, closing a stake of 12,154 shares — an estimated $54.7K sold.

B.O.S.S. Retirement Advisors first reported a position in LRMR in Q3 2025 and held it in 3 quarters. The position peaked at $55K in Q4 2025. 163 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.

  • B.O.S.S. Retirement Advisors reported no remaining Larimar Therapeutics position as of Q2 2026 after selling out during the quarter.
  • B.O.S.S. Retirement Advisors sold 12,154 Larimar Therapeutics shares in Q2 2026, an estimated $54.7K.
  • B.O.S.S. Retirement Advisors first reported a position in Larimar Therapeutics in Q3 2025 and held it in 3 quarters.
  • B.O.S.S. Retirement Advisors's Larimar Therapeutics position peaked at $55K in Q4 2025.
  • 163 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.

Based on B.O.S.S. Retirement Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.